Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy

Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Candidate: Mgr. Jana Rathouská Supervisor: Doc. PharmDr. Petr Nachtigal, Ph.D. Title of Doctoral Thesis: Pharmacological influence on atherogenesis in experimental animal models of athero...

Full description

Bibliographic Details
Main Author: Rathouská, Jana
Other Authors: Nachtigal, Petr
Format: Doctoral Thesis
Language:Czech
Published: 2014
Online Access:http://www.nusl.cz/ntk/nusl-334572
id ndltd-nusl.cz-oai-invenio.nusl.cz-334572
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-3345722018-11-16T04:17:47Z Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy Pharmacological Influence on Atherogenesis in Experimental Animal Models of Atherosclerosis Rathouská, Jana Nachtigal, Petr Vrablík, Michal Vohnout, Branislav Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Candidate: Mgr. Jana Rathouská Supervisor: Doc. PharmDr. Petr Nachtigal, Ph.D. Title of Doctoral Thesis: Pharmacological influence on atherogenesis in experimental animal models of atherosclerosis Atherosclerosis is a slow inflammatory process in arterial walls which is, as a part of cardiovascular diseases, the main source of morbidity and mortality in developed countries. However, searching for the possibilities of atherosclerosis treatment requires detailed knowledge of pathogenesis of the disease itself. The use of mouse models offers one of the possibilities of studying the pathogenesis of atherosclerosis, which enables a number of interventions that would not be acceptable in human medicine. By using the high content lipid diet, we are able to induce the changes of lipid spectrum in mice. Moreover, if a targeted genetic manipulation is used, one can reach considerably advanced plaques in a relatively short time period. It is also possible to interfere in the process of atherogenesis in mouse models by using some hypolipidemic drugs, for example from the statin group that were represented in our studies by atorvastatin. By observing the vessel's reactivity to atorvastatin dosage,... 2014 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-334572 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Candidate: Mgr. Jana Rathouská Supervisor: Doc. PharmDr. Petr Nachtigal, Ph.D. Title of Doctoral Thesis: Pharmacological influence on atherogenesis in experimental animal models of atherosclerosis Atherosclerosis is a slow inflammatory process in arterial walls which is, as a part of cardiovascular diseases, the main source of morbidity and mortality in developed countries. However, searching for the possibilities of atherosclerosis treatment requires detailed knowledge of pathogenesis of the disease itself. The use of mouse models offers one of the possibilities of studying the pathogenesis of atherosclerosis, which enables a number of interventions that would not be acceptable in human medicine. By using the high content lipid diet, we are able to induce the changes of lipid spectrum in mice. Moreover, if a targeted genetic manipulation is used, one can reach considerably advanced plaques in a relatively short time period. It is also possible to interfere in the process of atherogenesis in mouse models by using some hypolipidemic drugs, for example from the statin group that were represented in our studies by atorvastatin. By observing the vessel's reactivity to atorvastatin dosage,...
author2 Nachtigal, Petr
author_facet Nachtigal, Petr
Rathouská, Jana
author Rathouská, Jana
spellingShingle Rathouská, Jana
Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
author_sort Rathouská, Jana
title Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
title_short Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
title_full Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
title_fullStr Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
title_full_unstemmed Farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
title_sort farmakologické ovlivnění aterogeneze u experimentálních zvířecích modelů ateroskleózy
publishDate 2014
url http://www.nusl.cz/ntk/nusl-334572
work_keys_str_mv AT rathouskajana farmakologickeovlivneniaterogenezeuexperimentalnichzvirecichmodeluateroskleozy
AT rathouskajana pharmacologicalinfluenceonatherogenesisinexperimentalanimalmodelsofatherosclerosis
_version_ 1718791562703405056